These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12164258)

  • 1. A sensitive method for determining levels of [-]-2,5,-dimethoxy-4-methylamphetamine in the brain tissue.
    Eckler JR; Greizerstein H; Rabin RA; Winter JC
    J Pharmacol Toxicol Methods; 2001; 46(1):37-43. PubMed ID: 12164258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of DOM-induced stimulus control by fluoxetine and citalopram: role of pharmacokinetics.
    Eckler JR; Doat MM; Rabin RA; Winter JC
    Life Sci; 2002 Aug; 71(11):1341-7. PubMed ID: 12106599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas.
    Doat-Meyerhoefer MM; Hard R; Winter JC; Rabin RA
    Pharmacol Biochem Behav; 2005 Aug; 81(4):750-7. PubMed ID: 15972234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nefazodone in the rat: mimicry and antagonism of [-]-DOM-induced stimulus control.
    Eckler JR; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 2003 May; 75(2):405-10. PubMed ID: 12873632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents.
    Fiorella D; Palumbo PA; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 May; 119(2):239-45. PubMed ID: 7659772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of DOM-induced stimulus control by non-competitive NMDA antagonists: a link between the glutamatergic and serotonergic hypotheses of schizophrenia.
    Winter JC; Doat M; Rabin RA
    Life Sci; 2000 Dec; 68(3):337-44. PubMed ID: 11191649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotransmitter basis of the behavioral effects of hallucinogens.
    Rech RH; Commissaris RL
    Neurosci Biobehav Rev; 1982; 6(4):521-7. PubMed ID: 6817241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of delta 9-tetrahydrocannabinol levels in brain tissue using high-performance liquid chromatography with electrochemical detection.
    Nyoni EC; Sitaram BR; Taylor DA
    J Chromatogr B Biomed Appl; 1996 Apr; 679(1-2):79-84. PubMed ID: 8998573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM.
    Eckler JR; Chang-Fong J; Rabin RA; Smith C; Teitler M; Glennon RA; Winter JC
    Pharmacol Biochem Behav; 2003 Jul; 75(4):845-52. PubMed ID: 12957227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 2, 5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine for in vivo efflux of catecholamines from rat brain.
    Vrbanac JJ; Tilson HA; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1975; 3(1):57-64. PubMed ID: 1129355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM), 2,5-dimethoxy-4-ethylamphetamine (DOET), d-amphetamine, and cocaine in rats trained with mescaline as a discriminative stimulus.
    Winter JC
    Psychopharmacologia; 1975 Oct; 44(1):29-32. PubMed ID: 1197576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD.
    Doat MM; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 2003 Feb; 74(3):713-21. PubMed ID: 12543238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoradiography of LSD and 2,5-dimethoxyphenylisopropylamine psychotomimetics demonstrates regional, specific cross-displacement in the rat brain.
    McKenna DJ; Saavedra JM
    Eur J Pharmacol; 1987 Oct; 142(2):313-5. PubMed ID: 3691644
    [No Abstract]   [Full Text] [Related]  

  • 14. The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors.
    Winter JC; Filipink RA; Timineri D; Helsley SE; Rabin RA
    Pharmacol Biochem Behav; 2000 Jan; 65(1):75-82. PubMed ID: 10638639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.
    Fantegrossi WE; Harrington AW; Eckler JR; Arshad S; Rabin RA; Winter JC; Coop A; Rice KC; Woods JH
    Psychopharmacology (Berl); 2005 Sep; 181(3):496-503. PubMed ID: 15983786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct comparison of hallucinogenic phenethylamines and D-amphetamine on dorsal raphe neurons.
    Penington NJ; Reiffenstein RJ
    Eur J Pharmacol; 1986 Apr; 122(3):373-7. PubMed ID: 3709659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution profile of 2,5-dimethoxy-4-bromoamphetamine (DOB) in rats after oral and subcutaneous doses.
    Beránková K; Szkutová M; Balíková M
    Forensic Sci Int; 2007 Aug; 170(2-3):94-9. PubMed ID: 17629428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. II: Reassessment of LSD false positives.
    Fiorella D; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 Oct; 121(3):357-63. PubMed ID: 8584618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of chronic treatment with clozapine and haloperidol on stimulus control by DOM.
    Doat MM; Rabin RA; Winter JC
    Int J Neuropsychopharmacol; 2002 Jun; 5(2):153-8. PubMed ID: 12135540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo metabolism of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in the rat: identification of urinary metabolites.
    Kanamori T; Inoue H; Iwata Y; Ohmae Y; Kishi T
    J Anal Toxicol; 2002 Mar; 26(2):61-6. PubMed ID: 11916016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.